10,000 patients to reveal how safe midline catheters really are
NCT ID NCT07677696
First seen Jul 01, 2026 · Last updated Jul 01, 2026
Summary
This study follows 10,000 adults receiving a midline catheter for intravenous therapy lasting 1 to 4 weeks as part of routine care. Researchers track complications like infection, blockage, or blood clots to see how well these devices perform in everyday hospital settings. The goal is to provide clear evidence on whether midline catheters are a safe and effective choice for short-term IV access.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
midline catheter
What this could lead to
If successful, this study could confirm that midline catheters are a safe and effective option for short-term intravenous therapy, potentially reducing complications from other vascular access devices.
What could go wrong
As an observational study, it cannot prove cause and effect. Results may be influenced by differences in patient care or data collection across hospitals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASCULAR ACCESS DEVICES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zibo Central Hospital
RECRUITINGZibo, China
Contact Phone: •••-•••-•••• Email: •••••@•••••